GleamWall
中文EN

IART INTEGRA LIFESCIENCES HOLDINGS CORP

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 917520 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY0.8%
TTM net income YoY102.6%
TTM EPS YoY102.6%
Revenue 3-yr CAGR2.4%
Net income 3-yr CAGR-49.5%

Margins

Gross margin52.4%
Operating margin4.4%
Net margin0.8%
FCF margin5.2%
EBITDA margin—

Returns

ROE1.2%
ROA0.4%
ROIC (approx.)2.8%
Asset turnover0.46x

Leverage & solvency

Liabilities / assets69.6%
Debt / equity0.65x
Current ratio3.62x
Interest coverage0.79x

Cash quality & payout

Operating cash flow / net income10.79x
Accruals ratio-3.6%
Payout ratio—
Capex / revenue3.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$1.64B$1.61B
Cost of revenue$803.62M$728.47M
Gross profit$831.62M$882.06M
R&D expense$98.97M$115.38M
SG&A expense$699.70M$716.98M
Operating income-$493.37M$28.41M
Interest expense$86.25M$70.63M
Pretax income-$563.50M-$18.24M
Income tax-$47.03M-$11.29M
Net income-$516.47M-$6.94M
EBITDA-$448.57M$70.81M
EPS (basic)-6.74-0.09
EPS (diluted)-6.74-0.09
Weighted avg. shares (diluted)76.67M77.01M
Balance sheet
Cash & equivalents$235.05M$246.38M
Short-term investments$28.69M$27.19M
Receivables$278.85M$272.37M
Inventory$492.74M$429.09M
Current assets$1.16B$1.08B
PP&E, net$444.33M$405.72M
Goodwill$615.16M$1.10B
Intangibles$1.13B$1.21B
Total assets$3.60B$4.04B
Current liabilities$455.98M$922.13M
Long-term debt$726.56M$760.47M
Total debt$726.56M$760.47M
Total liabilities$2.56B$2.49B
Shareholders' equity$1.04B$1.55B
Net debt$491.51M$514.09M
Cash flow statement
Operating cash flow$50.38M$129.38M
Capital expenditure$81.44M$104.42M
Free cash flow-$31.05M$24.96M
Investing cash flow-$108.06M-$390.81M
Financing cash flow$28.34M$237.86M
Depreciation & amortization$44.80M$42.40M
Stock-based compensation$18.58M$24.38M
Share buybacks$221,000$52.47M

Free plan shows the latest 2 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.